{
    "nctId": "NCT05263362",
    "briefTitle": "An Integrated Optimization of Surgery and Radiotherapy Techniques to Improve Cosmetic Outcome and Quality of Life in Breast Conserving Therapy for Breast Cancer Patients (STARLINGS Study)",
    "officialTitle": "An Integrated Optimization of Surgery and Radiotherapy Techniques to Improve Cosmetic Outcome and Quality of Life in Breast Conserving Therapy for Breast Cancer Patients.",
    "overallStatus": "ENROLLING_BY_INVITATION",
    "conditions": "Breast Fibrosis, Breast Cancer, Breast Cancer Female, Breast Neoplasms, Breast Carcinoma in Situ, Breast Carcinoma",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 750,
    "primaryOutcomeMeasure": "Fibrosis of the breast as measured by CTCAE v5 scale",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female patients aged \u2265 18 years\n* History of BCT with adjuvant radiation therapy for non-metastatic, histologically proven invasive breast cancer or DCIS. In light of BCT adjuvant systemic treatment (i.e. endocrine therapy, chemotherapy and immune therapy) is allowed.\n* Operated between 1st of January 2016 and 31th of December 2020\n* Treated according to the currently applied dose fractionation schedules, i.e. whole breast radiotherapy (22, 23), with or without boost\n* Adequate understanding of the Dutch language and written informed consent\n\nExclusion Criteria:\n\n* Any breast surgery or re-irradiation on the breast area after BCT\n* Progression of disease (and additional treatment) since BCT\n* Patients who received partial breast irradiation\n* Current pregnancy or breast feeding",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}